☰

Philip M. McKenna, Ph.D. - Publications

Affiliations: 
2006 Thomas Jefferson University, Philadelphia, PA, United States 
Area:
Immunology, Molecular Biology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Prout A, Rustandi RR, Tubbs C, Winters MA, McKenna P, Vlasak J. Functional profiling of Covid 19 vaccine candidate by flow virometry. Vaccine. PMID 35985887 DOI: 10.1016/j.vaccine.2022.08.006  0.428
2010 Lai MT, Lu M, Felock PJ, Hrin RC, Wang YJ, Yan Y, Munshi S, McGaughey GB, Tynebor RM, Tucker TJ, Williams TM, Grobler JA, Hazuda DJ, McKenna PM, Miller MD. Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors. Antimicrobial Agents and Chemotherapy. 54: 4812-24. PMID 20805392 DOI: 10.1128/Aac.00829-10  0.372
2010 Bianchi E, Joyce JG, Miller MD, Finnefrock AC, Liang X, Finotto M, Ingallinella P, McKenna P, Citron M, Ottinger E, Hepler RW, Hrin R, Nahas D, Wu C, Montefiori D, et al. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates. Proceedings of the National Academy of Sciences of the United States of America. 107: 10655-60. PMID 20483992 DOI: 10.1073/Pnas.1004261107  0.664
2010 Wang YJ, McKenna PM, Hrin R, Felock P, Lu M, Jones KG, Coburn CA, Grobler JA, Hazuda DJ, Miller MD, Lai MT. Assessment of the susceptibility of mutant HIV-1 to antiviral agents. Journal of Virological Methods. 165: 230-7. PMID 20153375 DOI: 10.1016/j.jviromet.2010.02.002  0.378
2009 Lai MT, Munshi V, Touch S, Tynebor RM, Tucker TJ, McKenna PM, Williams TM, DiStefano DJ, Hazuda DJ, Miller MD. Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrobial Agents and Chemotherapy. 53: 2424-31. PMID 19289522 DOI: 10.1128/Aac.01559-08  0.455
2007 McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease. The Journal of Infectious Diseases. 195: 980-8. PMID 17330788 DOI: 10.1086/512243  0.731
2006 Plesa G, McKenna PM, Schnell MJ, Eisenlohr LC. Immunogenicity of cytopathic and noncytopathic viral vectors. Journal of Virology. 80: 6259-66. PMID 16775313 DOI: 10.1128/Jvi.00084-06  0.593
2006 McGettigan JP, Koser ML, McKenna PM, Smith ME, Marvin JM, Eisenlohr LC, Dietzschold B, Schnell MJ. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology. 344: 363-77. PMID 16226782 DOI: 10.1016/J.Virol.2005.09.004  0.691
2005 Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach. Virology. 331: 82-93. PMID 15582655 DOI: 10.1016/J.Virol.2004.10.018  0.727
2004 McKenna PM, Aye PP, Dietzschold B, Montefiori DC, Martin LN, Marx PA, Pomerantz RJ, Lackner A, Schnell MJ. Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque. Journal of Virology. 78: 13455-9. PMID 15564456 DOI: 10.1128/Jvi.78.24.13455-13459.2004  0.721
2003 McKenna PM, McGettigan JP, Pomerantz RJ, Dietzschold B, Schnell MJ. Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases. Current Hiv Research. 1: 229-37. PMID 15043205 DOI: 10.2174/1570162033485320  0.737
2003 McKenna PM, Pomerantz RJ, Dietzschold B, McGettigan JP, Schnell MJ. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes. Journal of Virology. 77: 12782-94. PMID 14610200 DOI: 10.1128/Jvi.77.23.12782-12794.2003  0.68
2003 McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, Schnell MJ. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome. Journal of Virology. 77: 10889-99. PMID 14512539 DOI: 10.1128/Jvi.77.20.10889-10899.2003  0.726
2003 McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. Journal of Virology. 77: 237-44. PMID 12477829 DOI: 10.1128/Jvi.77.1.237-244.2003  0.727
2002 McGettigan JP, McKenna PM, Schnell MJ. HIV-1 vaccines: the search continues. Clinics in Laboratory Medicine. 22: 799-820, viii. PMID 12244598 DOI: 10.1016/S0272-2712(02)00004-5  0.679
1998 Robert-Guroff M, Kaur H, Patterson LJ, Leno M, Conley AJ, McKenna PM, Markham PD, Richardson E, Aldrich K, Arora K, Murty L, Carter L, Zolla- Pazner S, Sinangil F. Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus Journal of Virology. 72: 10275-10280. PMID 9811775 DOI: 10.1128/Jvi.72.12.10275-10280.1998  0.65
1998 Geffin RB, Scott GB, Melenwick M, Hutto C, Lai S, Boots LJ, McKenna PM, Kessler JA, Conley AJ. Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1. Aids Research and Human Retroviruses. 14: 579-90. PMID 9591712  0.395
1997 Boots LJ, McKenna PM, Arnold BA, Keller PM, Gorny MK, Zolla-Pazner S, Robinson JE, Conley AJ. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries. Aids Research and Human Retroviruses. 13: 1549-59. PMID 9430247 DOI: 10.1089/Aid.1997.13.1549  0.353
1997 Kessler JA, McKenna PM, Emini EA, Chan CP, Patel MD, Gupta SK, Mark GE, Barbas CF, Burton DR, Conley AJ. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. Aids Research and Human Retroviruses. 13: 575-82. PMID 9135875  0.431
1996 Conley AJ, Kessler JA, Boots LJ, McKenna PM, Schleif WA, Emini EA, Mark GE, Katinger H, Cobb EK, Lunceford SM, Rouse SR, Murthy KK. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. Journal of Virology. 70: 6751-8. PMID 8794312  0.379
1994 Nguyen MH, Schinazi RF, Shi C, Goudgaon NM, McKenna PM, Mellors JW. Resistance of human immunodeficiency virus type 1 to acyclic 6- phenylselenenyl- and 6-phenylthiopyrimidines Antimicrobial Agents and Chemotherapy. 38: 2409-2414. PMID 7840579  0.348
Show low-probability matches.